PAHC250117C30000
- 0.00
- 0.000.00%
Phibro Animal Health Newsroom
$960 Mn Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine - Global Forecast to 2029 With GSK, Seppic, Croda, SPI Pharma, Phibro Animal Health, Agenus, Dynavax Technologies Dominating
Macroeconomic Woes, FX Headwind Drag NEOG Stock Down
Reasons to Retain Phibro Stock in Your Portfolio Now
Earnings Call Summary | Phibro Animal Health(PAHC.US) Q1 2025 Earnings Conference
The One-year Decline in Earnings Might Be Taking Its Toll on Phibro Animal Health (NASDAQ:PAHC) Shareholders as Stock Falls 11% Over the Past Week
Phibro Animal Health Price Target Raised to $25.00/Share From $20.00 by Morgan Stanley
Phibro Animal Health Analyst Ratings
Morgan Stanley Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Raises Target Price to $25
Should You Continue to Hold TMO Stock in Your Portfolio?
Top Premarket Gainers
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Should You Be Worried About Phibro Animal Health Corporation's (NASDAQ:PAHC) 6.7% Return On Equity?
Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
US Manufacturing Index Rises To 43, Highest Since 2020
Express News | FDA - Approved Paqflor (Florfenicol); Paqflor Is Sponsored by Phibro Animal Health Based in Teaneck, New Jersey
Express News | FDA - FDA Approves First Generic Florfenicol for Controlling Mortality in Freshwater-Reared Fish
There May Be Some Bright Spots In Phibro Animal Health's (NASDAQ:PAHC) Earnings
Phibro Animal Health Announces Leadership Transition Plans
Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) Is a Solid Choice
Phibro Animal Health Is Maintained at Underweight by Barclays